This video gives a layman's summary of our recent publication in the Journal of Clinical Medicine (JCM), an MDPI journal. @JCM_MDPI
Thanks to all authors from @BassettNetwork@VCUHealthHeart
Manuscript link: https://t.co/JjNda93omj.
Check it out 👇
https://t.co/BiFjEwAUt0
This is an important case for diastolic function assessment that was corrected in 2025 guideline.
A main lesson is " Diastolic Function can be normal with reduced EF and/ or myocardial infarction." We should not adjudicate diastolic dysfunction based on clinical data. Always use mitral e' (Echo tau), E/e' , and TR. This patient has relatively normal medial e'. IVRT was measured somewhat short, but is challenging to measure, sometimes. PV A reversal is a little high and ends after mitral A, so probably mildly increased LVEdP, but mean LV diastolic P is normal. 2016 guideline would have assessed his diastolic as grade 3. Will be nice to show normal TR velocity.
#JKnott @MayoClinicCV fellow presented our data that 22% of patients with reduced LVEF have normal DF by Echo and #AIECG.@SNagueh@AJamilTajik
#GDMTworks but major gaps persist in implementation. 🤔
Polypharmacy is cited as one explanation
💡What if we could consolidate???
Metoprolol + spiro + SGLT2i into 1 💊!!!
👉🏽Check out Rationale & design for POLY-HF a polypill strategy in HFrEF!!
🔥 results coming at #AHA25 — read here so you are prepped!! 👀
https://t.co/ShaSIzyk9X
#CardioTwitter #FunctionNotFailure #GDMTworks
Our #ATS2024 Poster on Bronchoscopic Lung Volume Reduction With Endobronchial Zephyr Valves; A Systematic Review and Meta-analysis. Abstract available at: https://t.co/rRc3dfUkSv
We are pleased to share our case report and comprehensive literature review on primary malignant melanoma of the lung. According to our literature search, only 75 cases have been reported to date. 👇
Primary Malignant Melanoma of the Lung https://t.co/nOsLKEMtyZ
IM PGY-3s and beyond: interested in a cardiology focus? Consider one of our two Heart Failure Scholar positions @VCUHealthHeart Enriched with QI, Scholarly Activities and Clinical preparation. DM me for more information.
P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events: @JACCJournals
*** Great - this is what @AHAScience recommended for older higher risk patients: @MichaelGNanna
25-point summary in am report: (they are short sentences 😱)
👇👇👇
Our recent paper in JICE!
It’s available in freeRead 👇for interested readers.
#FreeRead 📖: https://t.co/DSq7PuUJAh
Bottom line: Leadless pacemaker is safe in select population!
Young ♀️ w CKD on HD, seen in Cardiorenal clinic
Pt had torrential tricuspid regurgitation due to CVC induced leaflet perforation ➡️ She underwent tricuspid valve replacement surgery 🫀🔪
However, 1 month after discharge she is still using a wheelchair 🤔
1/12🧵